Beck Bode LLC’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,510
| Closed | -$1.24M | – | 155 |
|
|
2023
Q1 | $1.24M | Sell |
1,510
-201
| -12% | -$165K | 0.3% | 82 |
|
|
2022
Q4 | $1.23M | Buy |
1,711
+1,280
| +297% | +$924K | 0.28% | 81 |
|
|
2022
Q3 | $297K | Buy |
431
+4
| +0.9% | +$2.76K | 0.06% | 150 |
|
|
2022
Q2 | $252K | Sell |
427
-27
| -6% | -$15.9K | 0.05% | 161 |
|
|
2022
Q1 | $317K | Buy |
+454
| New | +$317K | 0.07% | 119 |
|
|
2021
Q4 | – | Sell |
-12,681
| Closed | -$7.67M | – | 100 |
|
|
2021
Q3 | $7.67M | Sell |
12,681
-191
| -1% | -$116K | 2.14% | 22 |
|
|
2021
Q2 | $7.19M | Buy |
12,872
+50
| +0.4% | +$27.9K | 1.98% | 23 |
|
|
2021
Q1 | $6.07M | Buy |
+12,822
| New | +$6.07M | 1.87% | 24 |
|
|
2020
Q4 | – | Sell |
-37
| Closed | -$21K | – | 217 |
|
|
2020
Q3 | $21K | Buy |
+37
| New | +$21K | 0.01% | 166 |
|
|
2020
Q2 | – | Sell |
-6,132
| Closed | -$3.23M | – | 54 |
|
|
2020
Q1 | $3.23M | Buy |
+6,132
| New | +$3.23M | 1.48% | 28 |
|